Is Hologic Stock a Risky Investment Ahead of Its Q3 Earnings Report?

The Zacks Consensus Estimate for third-quarter earnings per share (EPS) suggests a 0.9% decrease year over year to $1.05. The estimate has dropped by 1 cent in the past 60 days. The Zacks Consensus Estimate for third- quarter revenues currently stands at $1.01 billion, suggesting a 0.4% decline year over year. | | Q1 | Q2 | F1 | F2 | | --- | --- | --- | --- | --- | | Current | 1.05 | 1.09 | 4.19 | 4.50 | | 7 Days Ago | 1.05 | 1.09 | 4.19 | 4.50 | | 30 Days Ago | 1.05 | 1.09 | 4.19 | 4.50 | | 60 Days Ago | 1 ...